The association study showed that CTLA-4 or CD28 expression in the tumor or lymphocytes was not significantly associated with any of the other clinicopathological features examined including age, gender, UICC stage or WHO pathological type of the patients (Table 1). The gene discussed is CD28; the disease is neoplasm.